The Covid vaccines “are produced only by a few companies in a few countries; the formulas are protected by patents, which allow the companies that invested in their development, to be rewarded for their work,” the report notes. “But the patents also prevent lower-cost manufacturing and distribution of the vaccines in the poorer countries that need them as well.”